Australia markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6000-0.0300 (-1.84%)
At close: 04:00PM EDT
1.6000 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6566
Avg. Estimate-0.06-0.04-0.28-0.42
Low estimate-0.22-0.15-0.75-1.11
High estimate0.020.010.04-0.12
Year ago EPS-0.05-0.02-0.01-0.28
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6656
Avg. Estimate22.02M21.43M88.44M77.9M
Low estimate15M11M80M26M
High estimate27M27M108M108M
Year ago sales23.5MN/A101.21M88.44M
Sales growth (year/est)-6.30%N/A-12.60%-11.90%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.11-0.2-0.19-0.03
Actual EPS-0.05-0.020.040.01
Difference0.060.180.230.04
Surprise %54.50%90.00%121.10%133.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.06-0.04-0.28-0.42
7 days ago-0.05-0.02-0.19-0.37
30 days ago-0.07-0.02-0.24-0.37
60 days ago0-0.01-0.19-0.27
90 days ago-0.03-0.03-0.23-0.27
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCTMXIndustrySector(s)S&P 500
Current qtr.-20.00%N/AN/AN/A
Next qtr.-100.00%N/AN/AN/A
Current year-2,700.00%N/AN/AN/A
Next year-50.00%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A